Home > Financial Ratios > NEULAND LABORATORIES

NEULAND LABORATORIES
Core EBITDA Growth

    Back to All Ratios
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 68.7394.61-11.1854.0270.98

What is the latest Core EBITDA Growth ratio of NEULAND LABORATORIES ?

The latest Core EBITDA Growth ratio of NEULAND LABORATORIES is 68.73 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar202468.73
Mar202394.61
Mar2022-11.18
Mar202154.02
Mar202070.98

How is Core EBITDA Growth of NEULAND LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2024 68.73
-27.35
Mar2023 94.61
Positive
Mar2022 -11.18
Negative
Mar2021 54.02
-23.89
Mar2020 70.98 -

Other Financial Ratios of NEULAND LABORATORIES


Compare Core EBITDA Growth ratio of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹17,576.1 Cr -0.1% -4% 112.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,744.0 Cr -4.2% -7.7% 24.1% Stock Analytics
DIVIS LABORATORIES ₹152,209.0 Cr -0.6% -5.6% 57.5% Stock Analytics
CIPLA ₹117,762.0 Cr 3.3% -4.8% 6.5% Stock Analytics
DR REDDYS LABORATORIES ₹99,705.3 Cr -2.4% -12.8% 1.1% Stock Analytics
ZYDUS LIFESCIENCES ₹95,929.3 Cr -0.3% -2.1% 24.5% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

-0.1%

-4%

112.6%

SENSEX

0.3%

-1.8%

8.6%


You may also like the below Video Courses